- What is prostate cancer?
- What are the risk factors for prostate cancer?
- Can prostate cancer be prevented?
- Finding prostate cancer early
- What tests can detect prostate cancer early?
- American Cancer Society recommendations for prostate cancer early detection
- If prostate cancer screening test results aren’t normal
- What are the signs and symptoms of prostate cancer?
- Insurance coverage for prostate cancer screening
- Additional resources
Insurance coverage for prostate cancer screening
The American Cancer Society supports legislation assuring that men will receive insurance coverage for prostate screening exams. The Society recognizes that differing opinions exist as to whether early detection testing for prostate cancer lowers disease-specific mortality. Until such time when studies are conclusive, patients, in consultation with their doctors, should be free to determine on an individual basis whether testing is appropriate. Prostate cancer screening should not be prevented because of the reimbursement limitations of health insurance plans.
The American Cancer Society does not support routine testing for prostate cancer at this time because we believe proper pretest guidance and education is necessary. Doctors and other clinicians should provide information on the potential risks and benefits of PSA testing to appropriate patients, allowing them to make an informed decision on testing.
State efforts to ensure prostate cancer screening coverage
States have passed laws on a variety of issues relating to prostate cancer, including:
- Assured health insurance coverage for prostate cancer screening
- Public education on prostate cancer
- Prostate cancer research funds
Many states have laws assuring that private health insurers cover tests to detect prostate cancer, including the PSA test and DRE. Some states also assure that public employee benefit health plans provide coverage for prostate cancer screening tests. Most state laws assure annual coverage for men ages 50 and over and for high-risk men, ages 40 and over. High risk refers to African-American men and/or men with a family history of prostate cancer. Some states have slightly different coverage requirements.
Laws on coverage vary from state to state, so check with your insurer or with your state insurance commissioner’s office to see what’s covered.
Medicare covers prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE) once a year for all men with Medicare age 50 and over. There is no co-insurance and no Part B deductible for the PSA test. For other services, the beneficiary would pay 20% of the Medicare-approved amount after the yearly Part B deductible.
Last Medical Review: 10/17/2014
Last Revised: 01/06/2015